HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 86 filers reported holding HARPOON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $458,000 | -57.8% | 240,221 | +9.9% | 0.00% | -60.0% |
| Q1 2022 | $1,086,000 | +60.7% | 218,663 | +144.1% | 0.01% | +66.7% |
| Q4 2021 | $676,000 | +1.5% | 89,590 | +6.3% | 0.01% | -14.3% |
| Q3 2021 | $666,000 | -19.6% | 84,272 | +41.1% | 0.01% | -22.2% |
| Q2 2021 | $828,000 | -35.9% | 59,724 | -3.2% | 0.01% | -43.8% |
| Q1 2021 | $1,291,000 | – | 61,698 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,130,267 | $43,417,000 | 8.07% |
| MPM BioImpact LLC | 3,196,707 | $44,338,000 | 7.28% |
| Aquilo Capital Management, LLC | 712,674 | $9,885,000 | 2.57% |
| Logos Global Management LP | 800,000 | $11,096,000 | 0.93% |
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $3,364,000 | 0.86% |
| VR Adviser, LLC | 512,005 | $7,102,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 580,759 | $8,055,000 | 0.65% |
| Avidity Partners Management LP | 1,500,000 | $20,805,000 | 0.56% |
| Orbimed Advisors | 2,611,308 | $36,219,000 | 0.37% |
| Maven Securities LTD | 618,610 | $8,456,000 | 0.34% |